Sponsor Pipeline

Natera, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
15
Active Trials
7
Recruiting
10
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-14 NCT07214532
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Trial sites expanded: 39 -> 48 locations
2026-07-24 NCT07689812
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus…
Primary endpoint(s) modified
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-13 NCT07763197 Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive… Recruiting
2026-08-06 NCT07750886 Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin… Recruiting
2026-07-22 NCT07718633 Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients… Not Yet Recruiting
Active Trials by Phase
Not specified
15
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06620627 Prospective Collection of Samples to Enable the Development of Natera Screening Assay for… Colorectal Cancer Screening Recruiting
NCT07046585 Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population… Colo-rectal Cancer Recruiting
NCT07318051 Sample Collection for Ongoing Research and Product Evaluation Study Breast Cancer Recruiting
NCT06808880 EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND) Single Gene NIPT Recruiting
NCT07750886 Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin… Non-Hodgkin Lymphoma Recruiting
NCT07214532 Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer Breast Neoplasms Recruiting
NCT07763197 Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive… Non-Muscle Invasive Bladder Cancer Recruiting
NCT04091984 The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) Kidney Transplant Rejection Active, Not Recruiting
NCT05170425 LAMBDA 002 (Lung Registry) Study Lung Transplant Rejection Active, Not Recruiting
NCT05205551 Prospera Test Evaluation in Cardiac Transplant (ProTECT) Heart Transplant Rejection Active, Not Recruiting
NCT06414603 A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance… Heart Transplant Failure and Rejection Active, Not Recruiting
NCT07565857 Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa… Gastric-Esophageal Cancer Not Yet Recruiting
NCT07339384 Signatera Assessment in Early-Stage Endometrial Cancer Endometrial Cancer Not Yet Recruiting
NCT07718633 Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients… Kidney Transplant Not Yet Recruiting
NCT07689812 A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus… NSCLC (Advanced Non-small Cell Lung Cancer) Not Yet Recruiting
Disease Areas
Get alerts when Natera, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free